Thomas Kensler, PhD
Center & Institute Affiliation(s):
Bloomberg School of Public Health
Baltimore , Maryland
PhD , Massachusetts Institute of Technology
Research interests in my laboratory focus on the biochemical and molecular mechanisms involved in the induction of cancer by chemicals to serve as a basis for the prevention, interruption or reversal of these processes in man. One of the major mechanisms of chemical protection against carcinogenesis, mutagenesis and other forms of toxicity mediated by carcinogens is the induction of enzymes involved in their metabolism, particularly enzymes such as glutathione S-transferases, UDP-glucuronosyl transferases and NAD(P)H:quinone reductase that facilitate the detoxication and elimination of carcinogens. Furthermore, animal studies indicate that induction of these cytoprotective enzymes is a sufficient condition for obtaining chemoprevention and can be achieved in many target tissues by administering any of a diverse array of naturally-occurring and synthetic chemical agents. Our work utilizes animal and cell culture models to elucidate mechanisms of inhibition of aflatoxin hepatocarcinogenesis by dithiolethiones such as oltipraz, isothiocyanates such as sulforaphane and triterpenoids such as CDDO-Im. While induction of glutathione S-transferases clearly play an important role in chemoprevention of aflatoxin hepatocarcinogenesis, ongoing studies are seeking to identify additional genes induced by these agents. The Keap1-Nrf2 signaling pathway is activated by these classes of chemopreventive agents and leads to increased expression of genes that attenuate oxidative stress and inflammation among other actions. Their contributions to protection against carcinogenesis are under investigation.
A practical goal of our research has been to develop the tools to test the hypothesis that enzyme induction is a useful strategy for chemoprevention in humans. Hepatocellular carcinoma is the leading cause of cancer death in parts of Asia and Africa and may relate to hepatitis B virus infection and aflatoxin ingestion. Longitudinal surveys and prospective case-control studies in Qidong, P.R. China demonstrate consistent exposure of individuals in this region to aflatoxins and indicate a prime role for aflatoxin in the etiology of liver cancer, respectively. As a consequence, we have conducted clinical chemoprevention trials of oltipraz and other agents in Qidong. The initial randomized, placebo-controlled intervention of oltipraz demonstrated an increased excretion of aflatoxin-mercapturic acid, a derivative of the aflatoxin-glutathione conjugate, in the urine of participants receiving oltipraz. This study highlights the general feasibility of inducing Nrf2-regulated enzymes in humans. Follow-up trials are evaluating more effective agents and are assessing whether protective alterations in aflatoxin metabolism can be sustained for extended periods of time and whether diminished incidence of liver cancer can be achieved in this high-risk population.
Honors and Awards
2007 AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention
2009 Society of Toxicology Translational Impact Award
2009 Golden Apple Award for Excellence in Teaching in Public Health Studies, Johns Hopkins University (undergraduates)
2011 National Friendship Award, Beijing, People’s Republic of China
2012 Oxygen Club of California - Jarrow Formulas Health Science Prize (shared with Masayuki Yamamoto)
Environmental Health Sciences, chemical carcinogenesis, chemoprevention, hepatocarcinogenesis, reactive oxygen, antioxidants, enzyme induction, aflatoxin, oltipraz, chlorophyllin, sulforaphane, Keap1, Nrf2, triterpenoids
Kensler, T.W., Ng, D., Carmella, S.G., Chen, M., Jacobson, L.P., Muñoz, A., Egner, P.A., Chen, J.G., Qian, G.S., Chen, T.Y., Fahey, J.W., Talalay, P., Groopman, J.D., Yuan, J.M. and Hecht, S.S. (2012) Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis 33: 101-107.
Agyeman, A., Chaerkady, R., Shaw, P., Davidson, N.E., Visvanathan, K., Pandey, A., and Kensler, T.W. (2011) Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res. Treat., in press.
Egner, P.A., Chen, J.G., Wang, J.B., Wu, Y., Sun, Y. Lu, J.H., Zhu, J, Zhang, Y.H., Chen, Y.S., Friesen, M.D., Jacobson, L.P., Muñoz, A., Ng, D., Qian, G.S., Zhu, Y.R., Chen, T.Y., Botting, N.P., Zhang, Q.Z., Fahey, J.W., Talalay, P., Groopman, J.D., Kensler, T.W. (2011) Bioavailability of sulforaphane from two broccoli sprout beverages: Results of a short term, cross-over clinical trial in Qidong, China. Cancer Prev. Res. 4: 384-395.
Kensler, T.W., Roebuck, B.D., Wogan, G.N. and Groopman, J.D. (2011) Aflatoxin: A 50 year odyssey of mechanistic and translational toxicology. Toxicol. Sci., 120: 28-48.
Wakabayashi, N. Shin, S., Slocum, S., Agoston, E.S., Wakabayashi, J., Kwak, M.K., Misra, V., Biswal, S., Yamamoto, M. and Kensler, T.W. (2010) Regulation of Notch1 signaling by Nrf2: implications for tissue regeneration. Science Signaling 3: ra52.